MicroPort Scientific Corporation

853 KYG608371046

Advanced Medical Equipment & Technology

Delayed Hong Kong S.E. Other stock markets 03:02:31 19/09/2024 BST			5-day change	1st Jan Change
5.040 ^HKD	+5.66%		+9.35%	-40.26%

08-30	MicroPort Scientific Corporation Reports Earnings Results for the Half Year Ended June 30, 2024	CI
08-23	MicroPort CardioFlow Medtech to Buy Industrial Site from MicroPort Medical	MT

Cet article est rÃ©servÃ© aux membres

Pour dÃ©bloquer l'article, INSCRIVEZ-VOUS !

100% Free Registration

Vous êtes déja client ? Log In

Latest news about MicroPort Scientific Corporation

MicroPort Scientific Corporation Reports Earnings Results for the Half Year Ended June 30, 2024	08-30	CI
MicroPort CardioFlow Medtech to Buy Industrial Site from MicroPort Medical	08-23	MT
Chinese Regulator Approves MicroPort Scientific's Firesorb Stent for Marketing	07-31	MT
MicroPort Scientific Corporation Announces Firesorb Bioresorbable Coronary Scaffold System Obtained Approval for Marketing from the NMPA	07-30	CI
MicroPort Scientific Forecasts Up to 52% Decline in H1 Net Loss; Shares Rise 4%	07-26	MT
MicroPort Scientific Corporation Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2024	07-25	CI
MicroPort Scientific Forecasts Decline in Net Loss for H1 on Higher Revenue	07-09	MT
MicroPort Endovascular Expects Up to 30% Profit Growth in H1; Shares Rise 6%	07-02	MT
MicroPort Scientific Redeems $700 Million Convertible Bonds Ahead of 2026 Maturity	06-13	MT
Microport Scientific Corporation Announces Retirement of Non-Executive Directors	05-22	CI
MicroPort Scientific's 2023 Loss Widens Despite Revenue Growth	05-01	MT
Nomura Adjusts MicroPort Scientific’s Price Target to HK$6.71 From HK$7.19, Keeps at Neutral	04-09	MT
MicroPort Scientific to Receive $150 Million Loan Facility, $300 Million Credit Support to Repay Convertible Bonds	04-08	MT
MicroPort Scientific Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Nomura Adjusts MicroPort Scientific’s Price Target to HK$7.19 From HK$17.59, Keeps at Neutral	03-06	MT
MicroPort Scientific Corporation Provides Earnings Guidance for the Year Ended 31 December 2023	03-05	CI
MicroPort Scientific Corporation Reports Revenue Results for the Twelve Months Ended 31 December 2023	03-05	CI
MicroPort Scientific Unit to See Up to 38% Boost in 2023 Profit	01-30	MT
MicroPort Scientific Raises $220 Million from Convertible Bond Issue; To Buy Back, Cancel $217 Million of Existing Bonds	12-20	MT
Otsuka's Unit Remains as MicroPort Scientific's Thai Distributor Until 2026	12-18	MT
EV MedTech Raises 1.8 Billion Yuan from Placement	12-15	MT
MicroPort Scientific Says Businesses Maintain Steady Growth	12-11	MT
MicroPort Launches Tender Offer for Zero-Coupon Bonds Due 2026; To Issue New Debts Worth $220 Million	12-06	MT
MicroPort Scientific Names Dealer Managers for $700 Million Convertible Bond Buyback; Shares Plunge 19%	12-06	MT
Microport Neurotech Limited and Microport Scientific Corporation Agrees to Renew the 2022 Master Materials Procurement Agreement, the 2022 Master Supporting Services Procurement Agreement and the 2022 Master Catering Services Agreement	12-01	CI

Chart MicroPort Scientific Corporation

Duration

Period

More charts

MicroPort Scientific Corporation is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of medical products. The Company operates through seven segments. Orthopedics Devices segment researches, develops, manufactures and sells orthopedics devices. Cardiovascular Devices segment researches, develops, manufactures and sells cardiovascular devices, such as drug eluting stents. Endovascular Devices segment researches, develops, manufactures and sells endovascular devices. Electrophysiology Devices segment researches, develops, manufactures and sells electrophysiology devices. Neurovascular Devices segment researches, develops, manufactures and sells neurovascular devices. Surgical Management segment researches, develops, manufactures and sells surgical devices. Diabetes Care and Endocrinal Management segment researches, develops, manufactures and sells devices related to diabetes mellitus.

Employees

6,987

Sector

Advanced Medical Equipment & Technology

Calendar

25/03/2025 - Q4 2024 Earnings Release (Projected)

More about the company